Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. The company is headquartered in Toronto, Ontario and currently employs 12 full-time employees. The company went IPO on 2021-12-10. The firm is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
PBM stock price ended at $3.13 on Cuma, after rising 8.30%
On the latest trading day Feb 06, 2026, the stock price of PBM rose by 8.30%, climbing from $2.85 to $3.13. Throughout the session, the stock experienced a volatility of 18.91%, with prices fluctuating between a daily low of $2.75 and a high of $3.27. Alongside this price increase, trading volume also rose by 45.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 98.9K shares were traded, amounting to a market value of approximately $5.8M.
PBMTeknik Sinyalleri
Teknik Sinyaller Özeti
Satın Alma Sinyalleri 4
Nötr Sinyaller 2
Satış Sinyalleri 1
Strong Sell
Sell
Neutral
Buy
Strong Buy
PBM, şu anda 4 alım sinyali ve 1 satım sinyali vermektedir. Hisse senedi 12:00 AM'ten beri Yukarı trend durumundadır ve bu dönemde toplam 8.3% fiyat değişimi gerçekleşti. Genel olarak teknik göstergeler orta vadeli olarak Buy görünüm işaret etmektedir.
PBM için Boğa/Ayı Sinyalleri
Hareketli ortalamalar, RSI, MACD ve işlem hacmi gibi temel göstergeleri analiz ederek PBM için yükseliş ve düşüş sinyalleri üretiyoruz. Bu analizlerle daha bilinçli yatırım kararları verin.